Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-08-30 to 2022-09-21
Current total value of award: $59611.44
Description: 4558478291!TYSABRI 300 MG/15 ML VIAL 15ML